ASP2409

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP2409, covering 2014-06-24 to 2014-06-24. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate [Phase 1]

See pricing